Background There is considerable interest in the effectiveness of financial incentives in the
delivery of health care. Incentives may be used in an attempt to increase the use of evidence …

WHO Global Strategy for Containment of Antimicrobial Resistance Page 1 WHO/CDS/CSR/DRS/2001.2
DISTR: GENERAL ORIGINAL: ENGLISH WHO Global Strategy for Containment of …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

A generic medicine is a faithful copy of a mature drug—no longer under patent—marketed
with the chemical name of the active ingredient. This article analyses generics markets in …

The experience of General medical practitioner (GP) fundholding is analysed for evidence of
the response by family doctors to financial incentives. An analysis of consultant outreach, the …

Sweden's pharmaceutical expenditure has increased during the last decades. On 1 October
2002 mandatory generic substitution was introduced in Sweden with the purpose to reduce …

Objective The objective of this paper was to undertake a narrative review of the literature
regarding strategies and interventions promoting the acceptance and uptake of generic …

Clinical governance has achieved “band wagon” status in recent months in the United
Kingdom. 1–3 Yet there remains considerable confusion and uncertainty about its scope …

With prescribing expenditure rising and evidence of prescribing costs variation, general
practitioners (GPs) in the UK are under increasing pressure to contain spending. The …

Objectives We analyzed the effect of the outpatient prescription incentive program and price
cuts of listed medicines in South Korea on prescription drug expenditures and prescription …